Given the complexity of clinical studies and the multilevel nature of clinical data, it is difficult to obtain direct evidence that leptin resistance causes NAFLD from the available clinical research data, which need to be interpreted with caution. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.